TPO suppression was found to inhibit the proliferation and migration of NSCLC cells by regulating cyclin E1, cyclin E2, CDK2, P27, RhoA, RhoC and c‐Myc protein levels. The gene discussed is RHOA; the disease is non-small cell lung carcinoma.